Canine Oral Chewable Tablets Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

November 2017 | 221 pages | ID: C6DCF7F1B2DEN
Precision Business Insights (PBI)

Abstracts

Global Canine Oral Chewable Tablets Market

Canine Oral Chewable Tablets Market are the oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and fleas infections, and among others. Various additives and flavouring agents are used in the formulation of canine oral chewable tablets for masking the unpleasant taste and odour of the drugs. The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately.

The global canine oral chewable tablets market is growing at a significant CAGR due to increase in the adoption of canines. Rise in the expenditure in animal welfare and wellness, wider availability of the canine oral chewable tablets in the market, and rise in the prevalence of various canine diseases such as tick and fleas infections, anticipated to fuel the canine oral chewable tablets market over the forecast period. In addition, ease of administration of tablets compared with parenteral formulations, lack of nutrition values in the canine feed, and initiations taken by various pet organizations and NGOs for animal welfare are expected bolster the canine oral chewable tablets market over the forecast years. However, stringent regulatory policies for the approval of veterinary formulations, lack of awareness about the canine oral chewable tablets in rural areas, high cost of the products, and withdrawn of drugs from the market such as levothyroxine sodium due to FDA warning regarding the lack of approval might hinder the canine oral chewable tablets market growth in the coming future.

The Canine Oral Chewable Tablets Market is segmented on the basis of composition type, drug class, product availability, and distribution channel

Based on the composition type, Canine Oral Chewable Tablets Market is segmented into the following:

• Botanically synthesized
• Chemically synthesized

Based on the drug class, Canine Oral Chewable Tablets Market is segmented into the following:

• Analgesics
• Anti-infective
• Anti-ulcers
• Vitamins & minerals
• Cardiovascular drugs
• Others

Based on the application, canine oral chewable tablets market is segmented into the following:

• Gastrointestinal diseases
• Cardiovascular disorders
• Infectious diseases
• Nutritional supplements
• Others

Based on the product type, canine oral chewable tablets market is segmented into the following:

• Prescription
• Over the Counter (OTC)

Based on the distribution channel, Canine Oral Chewable Tablets Market is segmented into the following:

• Veterinary clinics
• Veterinary Pharmacies
• Online veterinary stores
• Others

The global canine oral chewable tablets market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the canine oral chewable tablets market. For instance, in December 2015, Boehringer Ingelheim acquired Merial (Sanofi animal health) for strengthening its product portfolio. In addition, in May 2014, Merck Animal Health received the FDA approval for its drug Bravecto (fluralaner) used in the treatment of fleas and ticks infections. Moreover, in December 2014, Putney, Inc. launched the Carprofen canine oral chewable tablets for the treatment of pain and inflammation.

Geographically, canine oral chewable tablets market is segmented into the following regions Viz. Europe, Latin America, Asia Pacific, North America, and the Middle East and Africa. North America holds a significant share in global canine oral chewable tablets owing to increase in the adoption of canines (according to American Pet Products Association, approximately 78 Mn canines were owned in the U.S.), rise in the awareness of canine’s health, growth in the expenditure on animal welfare, increase in the research and development activities for the innovation of new products for chronic canine diseases might fuel the canine oral chewable tablets market in the region. Asia Pacific accounts for key share, which is attributed to increasing in the prevalence of various canine microbial diseases due to unhygienic conditions, a rise in the expenditure on animal welfare, and diversification of business segment in Asia Pacific region by various manufacturers might bolster the canine oral chewable tablets market in Asia Pacific region. Europe holds a major share owing to increase the awareness about pet’s health, a rise in the prevalence of various canine diseases, lack of nutrition fortified canine feed, and rise in research and development activities for the canine oral chewable tablets market might propel the market growth in Europe region.

Some of the players in canine oral chewable tablets market are Zoetis, Inc. (Pfizer) (U.S), Virbac AH Inc. (France), Elanco (Eli Lilly and Co.) (U.S.), Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany), Pala-Tech Laboratories (U.S.), Bayer HealthCare LLC, (Bayer AG) (Germany), Merck Animal Health (Merck &co. Inc.) (U.S.), and Putney, Inc. (Dechra Pharmaceuticals) (U.K.) to name a few.

In February 2016, Zoetis Inc. received the FDA approval for Simparica, canine oral chewable tablets for the treatment of ticks and fleas infection

In March 2016, Virbac launched Movoflextm soft chews, as the canine joint health supplementation in the U.S.

Report Outline:

• The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
• The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments, and startup’s details that are working in the industry

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL CANINE ORAL CHEWABLE TABLETS MARKET INTRODUCTION

2.1. Global Canine Oral Chewable Tablets Market– Taxonomy
2.2. Global Canine Oral Chewable Tablets Market–Definitions
  2.2.1. Composition Type
  2.2.2. Drug Class

3. GLOBAL CANINE ORAL CHEWABLE TABLETS MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Canine Oral Chewable Tablets Market Dynamics – Factors Impact Analysis
3.6. Global Canine Oral Chewable Tablets Market– Recent Market Introductions

4. GLOBAL CANINE ORAL CHEWABLE TABLETS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL CANINE ORAL CHEWABLE TABLETS MARKET FORECAST, BY COMPOSITION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Botanically Synthesized
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Chemically Synthesized
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis

6. GLOBAL CANINE ORAL CHEWABLE TABLETS MARKET FORECAST, BY DRUG CLASS, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Analgesics
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Anti-infective
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Anti-ulcers
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Vitamins & Minerals
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Cardiovascular Drugs
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis
6.6. Others
  6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.6.3. Market Opportunity Analysis

7. GLOBAL CANINE ORAL CHEWABLE TABLETS MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Gastrointestinal Diseases
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Cardiovascular Disorders
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Disorders
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Cardiovascular Disorders
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Others
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis

8. GLOBAL CANINE ORAL CHEWABLE TABLETS MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Veterinary Clinics
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Veterinary Pharmacies
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Online Veterinary Pharmacies
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Others
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis

9. GLOBAL CANINE ORAL CHEWABLE TABLETS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Region, 2017 – 2023

10. NORTH AMERICA CANINE ORAL CHEWABLE TABLETS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Composition Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.1.1. Botanically Synthesized
    10.1.1.2. Chemically Synthesized
  10.1.2. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Analgesics
    10.1.2.2. Anti-infective
    10.1.2.3. Anti-ulcers
    10.1.2.4. Vitamins & Minerals
    10.1.2.5. Cardiovascular Drugs
    10.1.2.6. Others
  10.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.3.1. Gastrointestinal Diseases
    10.1.3.2. Cardiovascular Disorders
    10.1.3.3. Infectious Diseases
    10.1.3.4. Nutritional Supplements
    10.1.3.5. Others
  10.1.4. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.4.1. Veterinary Clinics
    10.1.4.2. Veterinary Pharmacies
    10.1.4.3. Online Veterinary Pharmacies
    10.1.4.4. Others
  10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    10.1.5.1. U.S.
    10.1.5.2. Canada
  10.1.6. North America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2017 – 2023
  10.1.7. North America Canine Oral Chewable Tablets Market Dynamics – Trends

11. EUROPE CANINE ORAL CHEWABLE TABLETS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Composition Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.1.1. Botanically Synthesized
    11.1.1.2. Chemically Synthesized
  11.1.2. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Analgesics
    11.1.2.2. Anti-infective
    11.1.2.3. Anti-ulcers
    11.1.2.4. Vitamins & Minerals
    11.1.2.5. Cardiovascular Drugs
    11.1.2.6. Others
  11.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Gastrointestinal Diseases
    11.1.3.2. Cardiovascular Disorders
    11.1.3.3. Infectious Diseases
    11.1.3.4. Nutritional Supplements
    11.1.3.5. Others
  11.1.4. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.4.1. Veterinary Clinics
    11.1.4.2. Veterinary Pharmacies
    11.1.4.3. Online Veterinary Pharmacies
    11.1.4.4. Others
  11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.5.1. Germany
    11.1.5.2. UK
    11.1.5.3. France
    11.1.5.4. Spain
    11.1.5.5. Italy
    11.1.5.6. Russia
    11.1.5.7. Poland
    11.1.5.8. Rest of Europe
  11.1.6. Europe Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2017 – 2023
  11.1.7. Europe Canine Oral Chewable Tablets Market Dynamics – Trends

12. ASIA-PACIFIC CANINE ORAL CHEWABLE TABLETS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Composition Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.1.1. Botanically Synthesized
    12.1.1.2. Chemically Synthesized
  12.1.2. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Analgesics
    12.1.2.2. Anti-infective
    12.1.2.3. Anti-ulcers
    12.1.2.4. Vitamins & Minerals
    12.1.2.5. Cardiovascular Drugs
    12.1.2.6. Others
  12.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.3.1. Gastrointestinal Diseases
    12.1.3.2. Cardiovascular Disorders
    12.1.3.3. Infectious Diseases
    12.1.3.4. Nutritional Supplements
    12.1.3.5. Others
  12.1.4. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.4.1. Veterinary Clinics
    12.1.4.2. Veterinary Pharmacies
    12.1.4.3. Online Veterinary Pharmacies
    12.1.4.4. Others
  12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    12.1.5.1. Japan
    12.1.5.2. China
    12.1.5.3. India
    12.1.5.4. ASEAN
    12.1.5.5. Australia & New Zealand
    12.1.5.6. Rest of Asia-Pacific
  12.1.6. Asia-Pacific Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2017 – 2023
  12.1.7. Asia-Pacific Canine Oral Chewable Tablets Market Dynamics – Trends

13. LATIN AMERICA CANINE ORAL CHEWABLE TABLETS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  13.1.1. Composition Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.1.1. Botanically Synthesized
    13.1.1.2. Chemically Synthesized
  13.1.2. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.2.1. Analgesics
    13.1.2.2. Anti-infective
    13.1.2.3. Anti-ulcers
    13.1.2.4. Vitamins & Minerals
    13.1.2.5. Cardiovascular Drugs
    13.1.2.6. Others
  13.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.3.1. Gastrointestinal Diseases
    13.1.3.2. Cardiovascular Disorders
    13.1.3.3. Infectious Diseases
    13.1.3.4. Nutritional Supplements
    13.1.3.5. Others
  13.1.4. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.4.1. Veterinary Clinics
    13.1.4.2. Veterinary Pharmacies
    13.1.4.3. Online Veterinary Pharmacies
    13.1.4.4. Others
  13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    13.1.5.1. Brazil
    13.1.5.2. Mexico
    13.1.5.3. Argentina
    13.1.5.4. Venezuela
    13.1.5.5. Rest of Latin America
  13.1.6. Latin America Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2017 – 2023
  13.1.7. Latin America Canine Oral Chewable Tablets Market Dynamics – Trends

14. MIDDLE EAST & AFRICA CANINE ORAL CHEWABLE TABLETS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  14.1.1. Composition Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.1.1. Botanically Synthesized
    14.1.1.2. Chemically Synthesized
  14.1.2. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.2.1. Analgesics
    14.1.2.2. Anti-infective
    14.1.2.3. Anti-ulcers
    14.1.2.4. Vitamins & Minerals
    14.1.2.5. Cardiovascular Drugs
    14.1.2.6. Others
  14.1.3. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.3.1. Gastrointestinal Diseases
    14.1.3.2. Cardiovascular Disorders
    14.1.3.3. Infectious Diseases
    14.1.3.4. Nutritional Supplements
    14.1.3.5. Others
  14.1.4. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    14.1.4.1. Veterinary Clinics
    14.1.4.2. Veterinary Pharmacies
    14.1.4.3. Online Veterinary Pharmacies
    14.1.4.4. Others
  14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    14.1.5.1. Gulf Cooperation Council (GCC) Countries
    14.1.5.2. Israel
    14.1.5.3. South Africa
    14.1.5.4. Rest of MEA
  14.1.6. MEA Canine Oral Chewable Tablets Market- Opportunity Analysis Index - By Drug Class, By Composition Type, By Application, By Distribution Channel, and Country, 2017 – 2023
  14.1.7. MEA Canine Oral Chewable Tablets Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Zoetis, Inc. (Pfizer) (U.S)
  15.2.2. Virbac AH Inc. (France)
  15.2.3. Elanco (Eli Lilly and Co.) (U.S.)
  15.2.4. Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
  15.2.5. Pala-Tech Laboratories (U.S.)
  15.2.6. Bayer HealthCare LLC, (Bayer AG) (Germany)
  15.2.7. Merck Animal Health (Merck &co. Inc.) (U.S.)
  15.2.8. Putney, Inc. (Dechra Pharmaceuticals) (U.K.)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS